Novavax Inc. Stock Falls Tuesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 1.80% to $10.89 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.90% to 12,113.79 and the Dow Jones Industrial Average rising 0.78% to 34,156.69. This was the stock's third consecutive day of losses. Novavax Inc. closed $84.45 short of its 52-week high ($95.34), which the company achieved on February 10th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.02% to $163.40, Pfizer Inc. (PFE) fell 0.39% to $43.59, and Merck & Co. Inc. (MRK) rose 1.59% to $105.68. Trading volume (5.3 M) remained 2.2 million below its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 7, 2023.
(END) Dow Jones Newswires
February 07, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.